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July 12, 2011:311–5of even minor troponin elevations (5). Maybe the time for
diagnostic criteria revision is coming.
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Reply
The apparent paradox of discrepant results of biomarker measure-
ments after percutaneous coronary intervention (PCI) has added
further confusion to our limited understanding of myocardial
injury that occurs during revascularization. In patients with com-
plex multivessel disease, this myocardial injury occurs equally
during either coronary artery bypass graft surgery or PCI despite
contemporary procedural technique (1). Myocardial injury during
PCI may be either adjacent, caused by occlusion of small side
branches during stent implantation, or downstream/distal, caused
by embolized atheroma/thrombotic material (2).
Our recent data suggest that higher levels of troponin elevation
orrelate well with creatine kinase-myocardial band (CK-MB)
levation after PCI (3), and we have previously shown that these
iomarker elevations reflect areas of myocardial infarction demon-
trable with cardiac magnetic resonance imaging (4). However, in
atients with lower levels of troponin elevation after PCI, CK-MB
s unlikely to be elevated. In these patients, there is limited
vidence of systemic inflammation and no evidence of myocardial
nfarction on magnetic resonance imaging.
When undertaking analyses of the clinical implication of these
maller troponin elevations after PCI, we should exclude the
otential bias of the higher troponin elevations, which, in my
pinion, have a clear prognostic consequence. Recently, Cavallini
t al. (5) have confirmed that smaller elevations of troponin after
CI (when CK-MB is normal) are principally a reflection of the
atient’s baseline risk profile and that the prognostic impact ismarginal. In my opinion, this particular clinical scenario of normal
CK-MB with small troponin rise would be best categorized in the
less emotive category “procedural necrosis” rather than “myocardial
infarction.”
Consequently, I agree with the recommendation of Lippi and
Cervellin that a change in the arbitrary threshold for procedural
infarction when measuring troponin after PCI would be useful.
This change in the “universal definition” may allow us to steer
safely between Scylla and Charybdis toward a better understanding
of revascularization injury and perhaps, ultimately, to the destina-
tion of abolishing it.
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“Universal Definition”
Methodology and
Conclusions Are a Concern
We congratulate Lim et al. (1) on their recent paper assessing this
area relevant to clinical practice, especially in light of sensitive
cardiac troponin (cTn) assays. However, we have important
concerns over the methodology and conclusions.
First, it seems inappropriate to use an insensitive test, late
gadolinium enhancement cardiac magnetic resonance (CMR), as a
gold standard diagnosis, to compare a sensitive test, cTn, with a
moderately sensitive test, creatine kinase-myocardial band (CK-
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July 12, 2011:311–5MB). Cardiac magnetic resonance is considered the gold standard
for quantification of ventricular volumes and global and regional
function/mass (2). It also allows detection of at least as small as
0.3 g of myocardial infarction (3), if the tissue damage is suffi-
ciently confluent to cause an imaging abnormality (4). It is difficult
to assess the volume of myonecrosis corresponding to 3 times the
99th percentile of cTn, which, if due to plaque embolization, is not
confluent. The results from Lim et al. (1) and others (3) suggesting
a lack of agreement between CMR and cTn for the diagnosis of
small-size periprocedural myocardial infarction could all be be-
cause of these differences. Our suggestion is that cTn should have
been used to diagnose myocardial infarction type 4a, and then
CMR would be the investigational test to be compared against that
gold standard (5). If so, it might have suggested the insensitivity of
CK-MB.
Second, the study showed a comparable area under the receiver-
operating characteristic curve for cTn and CK-MB for detection of
CMR late gadolinium enhancement (0.985 vs. 0.970, p  0.411).
ow possibly does this justify their statement to favor one marker
ver the other?
Third, multiple studies have unequivocally shown that pre-
rocedural cTn elevation is a powerful independent predictor of
eath after percutaneous coronary intervention (6). We would
uggest not to argue with death as an endpoint. Therefore,
isregarding cTn because of its “over-sensitivity,” and preferring
he less sensitive marker CK-MB, is not advisable.
In our opinion, rather than using CMR and cTn synergistically
7), this paper inappropriately had 1 play against the other to hide
n unpleasant truth: contemporary complex percutaneous coronary
ntervention results in periprocedural myocardial infarction in
any patients. Hiding or ignoring this important observation may
ithhold important benefit from our patients that could be
chieved by research focused on avoiding periprocedural myocar-
ial infarction.
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Reply
The “universal definition” of myocardial infarction (MI) catego-
rizes increasing evidence of myocardial injury during percutaneous
coronary intervention (PCI) as either no evidence of injury,
evidence of procedural necrosis, or evidence of type 4a MI (1). The
thresholds for biomarker abnormality to differentiate between
these categories were arbitrarily chosen. Our paper shows that an
important difference is evident in these thresholds when measuring
either creatine kinase-myocardial band (CK-MB) or troponin (2).
I agree that cardiac magnetic resonance (CMR) imaging with
late gadolinium enhancement is the most sensitive imaging mo-
dality for detection of focal myocardial injury, and we have
previously shown, using this technology, that we can detect
evidence of PCI-induced downstream plaque embolization and
associated myocardial necrosis (3). In my opinion, setting the
arbitrary threshold for diagnosis of MI at the currently defined
CK-MB threshold, which is approximately the lower limit of
detection by CMR, is both appropriate and pragmatic.
Using this threshold, either CK-MB or troponin can be
measured post-procedurally (with an appropriately adjusted
threshold for troponin-based MI categorization), and measure-
ments reaching this level and categorization would agree with the
general public’s perceptions of and implications of the diagnosis of
MI. Smaller levels of troponin elevation that are below the
sensitivity of CMR to detect injury can be categorized as proce-
dural necrosis.
To use evidence of any troponin elevation as a threshold for
diagnosis of MI would make most periprocedural MI invisible to
state-of-the-art magnetic resonance imaging and almost universal
during revascularization, particularly in the era of the newer, highly
sensitive troponin assays. Addressing this issue was one of the
principal aims of our paper, as patients with minor elevations of
troponin but no evidence of late gadolinium enhancement and
normal CK-MB would surely be better categorized as having
evidence of PCI-related myocardial necrosis instead of MI? That
would be more readily explicable to our patients, and consistent
with our data showing minimal inflammatory response in this
group and recently published prognostic data (4).
It is increasingly clear that the principal benefits of revascular-
ization are seen when ischemia is abolished. A degree of myocyte
